Login
← Go Back
Sequent Scientific
SEQUENT · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in
Stock Price vs Company Growth
1d
1.9%
1w
5.1%
1m
11.9%
3m
15.1%
6m
6.3%
1y
13.7%
5y
4.3%
all
1.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 210 1.9%
180
260
Company Overview
Sales
1,658 Cr
Growth: 10.6%
Profit after Tax
41.8 Cr
Growth: 40.9%
Small Cap
5,331 Cr
P/E: 128.7x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 1,658
Growth 10.6%
EBITDA 11.4%
P/S 3.2x
Dividend 0.0%
P/E 128.7x
Book Value ₹ 28.9
PEG Ratio 12.2x
ROE 5.9%
P/B 7.3x
Shareholding Pattern
Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Others
Increase    Decrease    No change
Company Profile Detailed
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Belongs to (11 Indices) view more
Investors (91)
sequent....
dilip.sh...
harish.n...
Followers (7)
jose4
joy2
ratnesh2